The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence

Title
The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence
Authors
Keywords
Major Depressive Disorder, Venlafaxine, Duloxetine, Evidence Review Group, Agomelatine
Journal
PHARMACOECONOMICS
Volume 34, Issue 9, Pages 901-912
Publisher
Springer Nature
Online
2016-06-11
DOI
10.1007/s40273-016-0417-9

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started